IP Library Granted Patent US 11,278,395
Granted Patent B2
US 11,278,395 · App. 16/913,255 · Granted Mar 22, 2022

Method for intraocular lens injector assembly having shuttle assembly retaining intraocular lens in storage vial and operably presenting intraocular lens in injector assembly

Inventors: Moises A. Valle (Tustin, CA); Madhu S. Ayyagari (Rancho Santa Margarita, CA); Sushant P. Muchhala (Aliso Viejo, CA); Sanjeev Bakshi (Trabuco Canyon, CA)
Assignee: BAUSCH & LOMB INCORPORATED
A61F2/1664A61F2/1667A61F2/1678A61F2/1691
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,395
App. No.
16/913,255
Granted
Mar 22, 2022
Kind
B2
Abstract

A shuttle, vial and injector are provided for storing and presenting an IOL to a patient. The shuttle includes operably engaged shuttle plates having a set of confronting surfaces that flex about a flexure interface between a storage configuration, with at least an optic of an IOL in a nominal state and a loading configuration, with at least an optic of an IOL in a deformed state. The vial engages the shuttle and maintains the shuttle in the storage configuration. The injector receives the shuttle from the vial and includes surfaces for flexing the portions of the shuttle plates to the loading configuration upon engagement with the injector, wherein the shuttle plates impart a predetermined curvature to at least a portion of the IOL.

Claims (17)

1. A method of disposing an IOL having an optic within a shuttle, the method comprising:

(a) locating an IOL on a fixture;

(b) capturing the IOL located on the fixture within an IOL chamber, the IOL chamber defined by an engaged first shuttle plate and second shuttle plate, the engaged first shuttle plate and a second shuttle plate defining a shuttle having the IOL chamber; and

(c) withdrawing the fixture from the IOL through a port in the IOL chamber to retain the IOL within the IOL chamber.

2. The method of claim 1 , further comprising retaining the IOL optic in a nominal state within the IOL chamber.

3. The method of claim 1 , further comprising engaging the shuttle with a vial, wherein the vial includes surfaces for disposing the first shuttle plate relative to the second shuttle plate in an engaged storage configuration, wherein the IOL is retained in a nominal state within the IOL chamber.

4. A method of removing a loaded shuttle retaining an IOL having an optic from a vial, the method comprising:

(a) opening the vial retaining sterile solution and the loaded shuttle operably engaged with the vial, the loaded shuttle having a first shuttle plate coupled to a second shuttle plate, and moveable between a coupled storage configuration and a coupled loading configuration, the coupled first shuttle plate and the second shuttle plate defining an IOL chamber retaining the IOL, the vial configured to flex the first shuttle plate and the second shuttle plate about a flexure interface to dispose the first shuttle plate and the second shuttle plate in the coupled storage configuration retaining the optic in a nominal state within the IOL chamber; and

(b) removing the loaded shuttle from operable engagement with the vial, wherein the shuttle is moved to the coupled loading configuration to impart a predetermined deformation of the optic.

5. A method of packaging an IOL, the method comprising:

(a) capturing an IOL within an IOL chamber formed by an operably coupled first shuttle plate and second shuttle plate to provide a loaded shuttle, the first shuttle plate and the second shuttle plate moveable between a coupled storage configuration and a coupled loading configuration;

(b) engaging the loaded shuttle with wedging surfaces of a vial to dispose the loaded shuttle in the coupled storage configuration, wherein the IOL chamber retains the IOL in a nominal state; and

(c) sterilizing the loaded shuttle in the vial.

6. A method for presenting an IOL to a patient, the method comprising:

(a) disengaging a loaded shuttle in a coupled storage configuration from a vial, the loaded shuttle having the IOL retained in an IOL chamber; and

(b) loading the loaded shuttle into an injector to transition the loaded shuttle from the coupled storage configuration to a coupled loading configuration, wherein the loaded shuttle includes a first shuttle plate and a second shuttle plate that flex about a flexure interface to simultaneously abut a storage set of confronting surfaces and a loading set of confronting surfaces of the first shuttle plate and the second shuttle plate, wherein the flexure interface is intermediate the storage set of confronting surfaces and the loading set of confronting surfaces and the coupled loading configuration of the loaded shuttle reduces a dimension of the IOL chamber and imparts a predetermined curvature of the IOL, the predetermined curvature inhibiting movement of the IOL along a shuttle lumen in the loaded shuttle.

7. The method of claim 6 , wherein disengaging the loaded shuttle from the vial, includes disengaging the loaded shuttle from a coupled storage configuration wherein the IOL chamber retains the IOL in a nominal state.

Assignments (15)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
PATENT SECURITY AGREEMENT Recorded Oct 4, 2023
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 065120/0086 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 054984/0345) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061849/0733 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 054984/0324) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061776/0058 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Jan 21, 2021
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; SOLTA MEDICAL, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 054984/0324 →
SECURITY INTEREST Recorded Jan 21, 2021
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; BAUSCH & LOMB INCORPORATED; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 054984/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2020
From: VALLE, MOISES A.; AYYAGARI, MADHU S.; MUCHHALA, SUSHANT P.; BAKSHI, SANJEEV
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 053058/0629 →